Navigation Links
Genzyme acquistion of Bone Care approved, significant impact forecast

Madison, Wis. - One of Wisconsin's most prominent pharmaceutical companies has been purchased, its stock delisted and its name changed. This move will result in a continued limited presence in Wisconsin, but could also create potential opportunites for the state's life science industry, increase distribution of their drug and has returned significant cash for the firm's investors.

......

Full article >>> company, those Bone Care employees not retained by Genzyme will be offered severance and outplacement assistance to help them transition to new employment.

Quinn said that while the company hopes to keep more than half of the existing staff - mostly in the sales and quality control divisions - executive positions will likely be offered severance packages.

"Since a lot of those po......

Full article >>> d the deals are usually successful for both parties. If a company as successful as Bone Care is purchased in Wisconsin it may help to draw more interest to the state, and having a large company like Genzyme holding office in the state could also help the industry get more momentum.

"The bottom line is we're hopeful the employee base remains in Dane County, but we're not in despair because......

Full article >>> hink this will set them up well for when they finally get a label for Renagel in the pre-dialysis market," Raymond said.......

Full article >>>
'"/>

Source:wistechnology.com By Les Chappell 07/01/05


Related biology technology :

1. Cytochroma settles lawsuit with Genzyme
2. Genzyme sues former Bone Care employees
3. Emerging technology companies receive significant funding
4. Proposed telecom bill would have Katrina impact
5. Shades of gray: Business impacts of an aging workforce
6. Javas undeniable impact on the Web
7. The flattening world and its impact on U.S. biotech
8. Doyle signs bill that impacts electronic medical records
9. RFID starting to make real impact on business
10. Transition continues to impact Third Wave financials
11. The impact of ACT 255 on the future of high-tech investment in Wisconsin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/20/2017)... ... July 20, 2017 , ... ... digital pathology and artificial intelligence Tuesday, July 25, during the Association of Pathology ... Johns Hopkins Medicine. , Baras, Associate Director of Pathology Informatics, will present ...
(Date:7/18/2017)... , ... July 18, 2017 , ... Sourcing custom glass ... your needs and has the capabilities to properly execute your job can take many ... is a sourcing portal designed to showcase the company’s capabilities and core ...
(Date:7/18/2017)... ... July 18, 2017 , ... Recently ... ( https://dataformsoftware.com ) announces the migration of its flagship cloud-based product Planet Life ... a team-centric, enterprise work management system that merges strategic and financial planning with ...
(Date:7/17/2017)... ... July 17, 2017 , ... Neurodevelopmental disorders ... range of overlapping clinical features. The advancement of targeted next-generation sequencing (NGS) has ... research and testing. , However, designing a custom panel for disease research ...
Breaking Biology Technology:
(Date:4/17/2017)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... 2016 Annual Report on Form 10-K on Thursday April 13, 2017 ... ... Investor Relations section of the Company,s website at http://www.nxt-id.com  under ... http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/11/2017)... Fla. , April 11, 2017 ... and secure authentication solutions, today announced that it ... Intelligence Advanced Research Projects Activity (IARPA) to develop ... Thor program. "Innovation has been a ... IARPA,s Thor program will allow us to innovate ...
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
Breaking Biology News(10 mins):